BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3855694)

  • 1. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide.
    Marks ME; Ziober BL; Brattain MG
    Cancer Res; 1985 Mar; 45(3):1276-84. PubMed ID: 3855694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
    Marks ME; Ziober BL; Brattain MG
    Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of normal growth control and membrane antigen composition in malignant cells by N,N-dimethylformamide.
    Chakrabarty S; McRae LJ; Levine AE; Brattain MG
    Cancer Res; 1984 May; 44(5):2181-5. PubMed ID: 6608991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective phosphorylation of cytosol proteins associated with transformation and restoration of normal phenotype in AKR mouse embryo fibroblasts.
    Chakrabarty S; Jan Y; Son J; Miller CA; Brattain MG
    Cancer Res; 1985 May; 45(5):2170-6. PubMed ID: 3872713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of fibronectin synthesis and fibronectin binding during transformation and differentiation of mouse AKR fibroblasts.
    Varani J; Chakrabarty S
    J Cell Physiol; 1990 Jun; 143(3):445-54. PubMed ID: 2141611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation-related alterations in the plasma membranes of chemically transformed murine fibroblasts.
    Chakrabarty S; Jan Y; Varani J
    Anticancer Res; 1990; 10(5A):1319-28. PubMed ID: 2241109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.
    Levine AE; McRae LJ; Brattain MG
    Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
    Levine AE; Crandall CA
    Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
    Mulder KM; Levine AE; Hinshaw XH
    Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of fibronectin, laminin, and cellular adhesion in the transformation and differentiation of murine AKR fibroblasts.
    Chakrabarty S; Brattain MG; Ochs RL; Varani J
    J Cell Physiol; 1987 Dec; 133(3):415-25. PubMed ID: 3320063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of difluoromethylornithine and dicyclohexylammonium sulfate on the transformed state of AKR-MCA cells.
    Boyd D; Bialoski S; Brattain MG
    Cancer Res; 1987 Aug; 47(15):4099-104. PubMed ID: 3111681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of growth inhibitory activity in transformed mouse embryo fibroblasts.
    Levine AE; Crandall CA; Brattain MG
    Exp Cell Res; 1987 Aug; 171(2):357-66. PubMed ID: 2887448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated growth factor levels in transformed mouse embryo cells treated with N,N-dimethylformamide.
    Levine AE; Hamilton DA; McRae LJ; Brattain MG
    Cancer Res; 1985 Jan; 45(1):108-11. PubMed ID: 2981156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of AKR fibroblast phenotype by fibronectin: regulation of cell-surface fibronectin binding receptor by fibronectin.
    Huang S; Varani J; Chakrabarty S
    J Cell Physiol; 1994 Dec; 161(3):470-82. PubMed ID: 7962129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor production by chemically transformed cells.
    Moses HL; Branum EL; Proper JA; Robinson RA
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the glucose-regulated gene encoding the Mr 78,000 glucose-regulated protein in chemically and radiation-transformed C3H 10T1/2 mouse embryo cells.
    Patierno SR; Tuscano JM; Kim KS; Landolph JR; Lee AS
    Cancer Res; 1987 Dec; 47(23):6220-4. PubMed ID: 2445468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous maintenance of transformed fibroblasts under reduced serum conditions: utility as a model system for investigating growth factor-specific effects in nonquiescent cells.
    Mulder KM; Brattain MG
    J Cell Physiol; 1989 Mar; 138(3):450-8. PubMed ID: 2647770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cellular phosphoprotein profiles in transformation and redifferentiation of murine AKR embryonic fibroblastic cells.
    Chakrabarty S; Brattain MG
    Cancer Lett; 1985 Nov; 29(2):151-5. PubMed ID: 3865700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.